[HTML][HTML] Pharmacogenetic meta-analysis of genome-wide association studies of LDL cholesterol response to statins

I Postmus, S Trompet, HA Deshmukh… - Nature …, 2014 - nature.com
Statins effectively lower LDL cholesterol levels in large studies and the observed
interindividual response variability may be partially explained by genetic variation. Here we …

[HTML][HTML] Statin pharmacogenomics: pursuing biomarkers for predicting clinical outcomes

JP Kitzmiller, PF Binkley, SR Pandey, AM Suhy… - Discovery …, 2013 - ncbi.nlm.nih.gov
Indicated for treating hyperlipidemias and for the prevention of cardiovascular disease
(CVD), statins rank among the most commonly prescribed drug classes. While statins are …

Pharmacogenetics and statin treatment: reality or theory?

E Bousoula, V Kolovou, D Perrea… - Current vascular …, 2015 - ingentaconnect.com
Pharmacogenetics investigates heritable genetic polymorphisms that can effect responses
to drug therapy. The main application of pharmacogenetics is genotype-guided dosing of …

[HTML][HTML] SLCO1B1 phenotype and CYP3A5 polymorphism significantly affect atorvastatin bioavailability

P Zubiaur, MD Benedicto, G Villapalos-García… - Journal of Personalized …, 2021 - mdpi.com
Atorvastatin, prescribed for the treatment of hypercholesterolemia, demonstrated
overwhelming benefits in reducing cardiovascular morbidity and mortality. However, many …

Pharmacogenomics of statin responsiveness

K Kajinami, H Akao, E Polisecki, EJ Schaefer - The American journal of …, 2005 - Elsevier
Statins are widely prescribed and are established as first-line therapy for the primary and
secondary prevention of coronary artery disease. However, the benefit of treatment varies …

[HTML][HTML] Pharmacogenetic foundations of therapeutic efficacy and adverse events of statins

E Arrigoni, M Del Re, L Fidilio, S Fogli… - International Journal of …, 2017 - mdpi.com
Background: In the era of precision medicine, more attention is paid to the search for
predictive markers of treatment efficacy and tolerability. Statins are one of the classes of …

Pharmacogenetics of statins treatment: Efficacy and safety

ZW Guan, KR Wu, R Li, Y Yin, XL Li… - Journal of Clinical …, 2019 - Wiley Online Library
What is known and objective Statins are widely used worldwide in the prevention and
treatment of coronary atherosclerotic heart disease and ischaemic stroke. However, in …

[PDF][PDF] Impact of variants within seven candidate genes on statin treatment efficacy

M Vrablík, JA Hubácek, D Dlouhá, V Lánská… - Physiological …, 2012 - biomed.cas.cz
Statins are the most commonly used drugs in patients with dyslipidemia. Among the patients,
a significant inter-individual variability with supposed strong genetic background in statin …

Genomewide association study of simvastatin pharmacokinetics

AJH Mykkänen, S Taskinen… - Clinical …, 2022 - Wiley Online Library
We investigated genetic determinants of single‐dose simvastatin pharmacokinetics in a
prospective study of 170 subjects and a retrospective cohort of 59 healthy volunteers. In a …

Impact of common genetic variation on response to simvastatin therapy among 18 705 participants in the Heart Protection Study

JC Hopewell, S Parish, A Offer, E Link… - European heart …, 2013 - academic.oup.com
Aims Statins reduce LDL cholesterol (LDL-C) and the risk of vascular events, but it remains
uncertain whether there is clinically relevant genetic variation in their efficacy. This study of …